Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ikaros (IKZF1) is a zinc-finger DNA-binding protein and transcription factor crucial for hematopoiesis and immune cell development, especially in B cells and CD4+ T cells. It functions as both a transcriptional activator and repressor through cofactor interactions and chromatin modification. Dysfunction is linked to leukemia, particularly B-cell ALL, and other immune disorders. It regulates the expression of key genes involved in immune cell differentiation and cytokine production.
Transcriptional activation or repression via co-factor interactions and chromatin modification (e.g., recruitment of histone deacetylase complexes)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ikaros Transcription Factor (IKZF1).